TenderlineUK
Procurement Intelligence
Search
Find a TenderAwarded
Published 29 Apr 2021, 13:43 BST

Official UK procurement notice

NHS National Generic Pharmaceuticals Transition 2021_1

Official notice

Authority: The NHS Commissioning Board (operating under the name of NHS England) (NHS & healthcare)

Framework agreement4 lotsGoodsOpen procedureSME suitable
Sectors: Medical Devices & Pharma (33) Delivery: UK
Framework ceiling (notional)Value not publishedframework ceiling, not attributable revenue
Awarded 17 Mar 2021
Lots 4see the lot list below

What is being bought4 lots · detail below

Published requirement description

Transition and 33 % products:CESW 15 April 2021 to 30 September 2021 (5.5 months);LSNE 15 April 2021 to 28 February 2022 (10.5 months);NWLN 15 April 2021 to 30 June 2022 (14.5 months);100 % Products (All Regions): 15 April 2021 to 28 February 2022 (10.5 months).The total maximum duration of the framework agreement to be no more than 29 months (14.5 months plus options to extend (at the Authority's sole discretion) for up to a further 14.5 months).

CPV: Pharmaceutical products · Various medicinal products

How this framework works

From the published notice
Bids received
26 bids on the busiest of 4 lots · 20 suppliers appointed

Lots and requirements (4)Procurement structure

4 lots · no lot values published
Lot #1Transition 2021_1 - 100% Products (All regions)Awarded

NHS National Pharmaceuticals Transition 2021_1 Offer reference number: CM/PHG/20/5629 Period of framework agreement: the total maximum duration of the framework agreement to be no more than 29 months (14.5 months plus options to extend (at the Authority's sole discretion) for up to a further 14.5 months) Potential Periods of call-offs under the framework agreement Transition and 33 % Products:CESW 15 April 2021 to 30 September 2021 (5.5 months);LSNE 15 April 2021 to 28 February 2022 (10.5 months);NWLN 15 April 2021 to 30 June 2022 (14.5 months);100 % Products (All Regions): 15 April 2021 to 28 February 2022 (10.5 months). Additional information: Price is not the only award criterion and all criteria are stated only in the procurementdocuments

Delivery: UK · Please refer to Document 3, Schedule 8 in the ITO documents for the list of purchasing points
Extensions: Options to extend (at the Authority's sole discretion) for up to a further 10.5 months.
33600000 Pharmaceutical products
Lot #2Transition 2021_1 - CESW region (Transition & 33% products)Awarded

NHS National Pharmaceuticals Transition 2021_1 Offer reference number: CM/PHG/20/5629 Period of framework agreement: the total maximum duration of the framework agreement to be no more than 29 months (14.5 months plus options to extend (at the Authority's sole discretion) for up to a further 14.5 months) Potential Periods of call-offs under the framework agreement Transition and 33 % Products:CESW 15 April 2021 to 30 September 2021 (5.5 months);LSNE 15 April 2021 to 28 February 2022 (10.5 months);NWLN 15 April 2021 to 30 June 2022 (14.5 months);100 % Products (All Regions): 15 April 2021 to 28 February 2022 (10.5 months) Additional information: Price is not the only award criterion and all criteria are stated only in the procurementdocuments

Delivery: UK · Please refer to Document 3, Schedule 8 in the ITO documents for the list of purchasing points
Extensions: Options to extend (at the Authority's sole discretion) for up to a further 5.5 months.
33690000 Various medicinal products
Lot #3Transition 2021_1 - LSNE region (Transition & 33% products)Awarded

NHS National Pharmaceuticals Transition 2021_1 Offer reference number: CM/PHG/20/5629 Period of framework agreement: the total maximum duration of the framework agreement to be no more than 29 months (14.5 months plus options to extend (at the Authority's sole discretion) for up to a further 14.5 months) Potential Periods of call-offs under the framework agreement Transition and 33 % Products:CESW 15 April 2021 to 30 September 2021 (5.5 months);LSNE 15 April 2021 to 28 February 2022 (10.5 months);NWLN 15 April 2021 to 30 June 2022 (14.5 months);100 % Products (All Regions): 15 April 2021 to 28 February 2022 (10.5 months)

Delivery: UK · Please refer to Document 3, Schedule 8 in the ITO documents for the list of purchasing points
Extensions: Options to extend (at the Authority's sole discretion) for up to a further 10.5 months.
33690000 Various medicinal products
Lot #4Transition 2021_1 - NWLN region (Transition & 33% products)Awarded

NHS National Pharmaceuticals Transition 2021_1 Offer reference number: CM/PHG/20/5629 Period of framework agreement: the total maximum duration of the framework agreement to be no more than 29 months (14.5 months plus options to extend (at the Authority's sole discretion) for up to a further 14.5 months) Potential Periods of call-offs under the framework agreement Transition and 33 % Products:CESW 15 April 2021 to 30 September 2021 (5.5 months);LSNE 15 April 2021 to 28 February 2022 (10.5 months);NWLN 15 April 2021 to 30 June 2022 (14.5 months);100 % Products (All Regions): 15 April 2021 to 28 February 2022 (10.5 months). Additional information: Price is not the only award criterion and all criteria are stated only in the procurementdocuments

Delivery: UK · Please refer to Document 3, Schedule 8 in the ITO documents for the list of purchasing points
Extensions: Options to extend (at the Authority's sole discretion) for up to a further 14.5 months.
33690000 Various medicinal products

What it takes to win
i

How this buyer will score bids.

The evaluation criteria and weights exactly as published on the notice, grouped by family (price, quality, social value and so on).

Evaluation split and conditions of participation as published; the tender pack may add more
What this means for your bid
  • “NHS National Generic Pharmaceuticals Transition 2021_1” is a framework: the contest is a place on its panel, not a single contract.

Procedure terms & legal framework

From the official record
Procedure method
Open procedure
Legal basis
CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
Procurement category
Goods
Notice status
Awarded
Procurement threshold
Unspecified in notice
Regulatory regime
Standard
Commercial structure
Framework agreement
Who may use this agreement
Not stated in the notice; call-off rights may be limited to the establishing authority
Competition type
Competitive procedure
GPA / WTO covered
Yes (GPA)
Recurring procurement
Unspecified in notice
First published
29 Apr 2021, 13:43 BST
Last source update
29 Apr 2021, 13:43 BST
Authority reference
CM/PHG/20/5629
FTS notice number
2021/S 000-009271
Classification (CPV)
Pharmaceutical productsVarious medicinal products
Delivery area
UK
Official registry OCID
ocds-h6vhtk-02aba8 Find a Tender

Commercial outcome & contract awards

Published awards, contracts and bid statistics, not a forecast
Suppliers appointed 20admitted to the panel · see the list ↓
Bids received 2611 from SMEs · busiest of 4 lots
Contracts signed 20latest 17 Mar 2021

39 suppliers are admitted to this framework without individual award values or dates, see the supplier list below.

Contracts

All 20 of these contracts carry the same published figure, £1, the framework's maximum for the whole notice, not each contract's own value. They are not eleven separate sums.

  • Transition 2021_1 - 100% Products (All regions)

    Signed
    17 Mar 2021
    Value
    ceiling above
    Status
    active

  • Transition 2021_1 - CESW region (Transition & 33% products)

    Signed
    17 Mar 2021
    Value
    ceiling above
    Status
    active

  • Transition 2021_1 - CESW region (Transition & 33% products)

    Signed
    17 Mar 2021
    Value
    ceiling above
    Status
    active

  • Transition 2021_1 - CESW region (Transition & 33% products)

    Signed
    17 Mar 2021
    Value
    ceiling above
    Status
    active

  • Transition 2021_1 - CESW region (Transition & 33% products)

    Signed
    17 Mar 2021
    Value
    ceiling above
    Status
    active

  • Transition 2021_1 - CESW region (Transition & 33% products)

    Signed
    17 Mar 2021
    Value
    ceiling above
    Status
    active

  • Transition 2021_1 - CESW region (Transition & 33% products)

    Signed
    17 Mar 2021
    Value
    ceiling above
    Status
    active

  • Transition 2021_1 - CESW region (Transition & 33% products)

    Signed
    17 Mar 2021
    Value
    ceiling above
    Status
    active

  • Transition 2021_1 - CESW region (Transition & 33% products)

    Signed
    17 Mar 2021
    Value
    ceiling above
    Status
    active

  • Transition 2021_1 - LSNE region (Transition & 33% products)

    Signed
    17 Mar 2021
    Value
    ceiling above
    Status
    active

  • Transition 2021_1 - LSNE region (Transition & 33% products)

    Signed
    17 Mar 2021
    Value
    ceiling above
    Status
    active

  • Transition 2021_1 - 100% Products (All regions)

    Signed
    17 Mar 2021
    Value
    ceiling above
    Status
    active

  • Transition 2021_1 - LSNE region (Transition & 33% products)

    Signed
    17 Mar 2021
    Value
    ceiling above
    Status
    active

  • Transition 2021_1 - LSNE region (Transition & 33% products)

    Signed
    17 Mar 2021
    Value
    ceiling above
    Status
    active

  • Transition 2021_1 - LSNE region (Transition & 33% products)

    Signed
    17 Mar 2021
    Value
    ceiling above
    Status
    active

  • Transition 2021_1 - LSNE region (Transition & 33% products)

    Signed
    17 Mar 2021
    Value
    ceiling above
    Status
    active

  • Transition 2021_1 - LSNE region (Transition & 33% products)

    Signed
    17 Mar 2021
    Value
    ceiling above
    Status
    active

  • Transition 2021_1 - LSNE region (Transition & 33% products)

    Signed
    17 Mar 2021
    Value
    ceiling above
    Status
    active

  • Transition 2021_1 - LSNE region (Transition & 33% products)

    Signed
    17 Mar 2021
    Value
    ceiling above
    Status
    active

  • Transition 2021_1 - LSNE region (Transition & 33% products)

    Signed
    17 Mar 2021
    Value
    ceiling above
    Status
    active

Bid statistics published by the authority

LotBidsSMEVCSEValid bid range
1 · Transition 2021_1 - 100% Products (All regions)14bids · 14 electronic · 14 from abroad7——
2 · Transition 2021_1 - CESW region (Transition & 33% products)26bids · 26 electronic · 26 from abroad11——
3 · Transition 2021_1 - LSNE region (Transition & 33% products)26bids · 26 electronic · 26 from abroad11——
4 · Transition 2021_1 - NWLN region (Transition & 33% products)26bids · 26 electronic · 26 from abroad11——

Contracting authority & participating public bodies

The NHS Commissioning Board (operating under the name of NHS England)

Contracting authorityNHS & healthcareMinistry or any other national or federal authority, including their regional or local subdivisionsHealth 2nd Floor, Rutland House, Runcorn, UK, WA7 2ESContact name, email

Dispute resolution & review bodies

  • The High CourtReview body LondonContact email

Framework contractors & participating bidders

20 commercial parties on the notice
Show 10 more suppliers
  • Martindale PharmaFramework contractor Building A2 Glory Park Avenue, Wooburn Green, High Wycombe, UK
  • Morningside PharmaeuticalsFramework contractor 5 Pavilion Way, Castle Business Park,, Loughborough, UK, LE11 5GW
  • Panpharma UK LimitedFramework contractor Cotton exchange, Bixteth street, Liverpool, UK, L3 9LQ
  • Pfizer LtdFramework contractor Walton Oaks, Dorking Road, Walton-on-the-Hill,, Tadworth, UK, KT20 7NS
  • Ranbaxy UKFramework contractor 5th Floor, Hyde Park11 Millington Road, Hayes, UK, UB3 4AZ
  • Selective Supplies Ltd.Framework contractor 25 Lucastes Lane, Haywards Heath, UK, RH16 1LE
  • Teva UK LimitedFramework contractor Ridings Point, Whistler Drive, Castleford, UK, WF10 5HX
  • Thornton and Ross LtdFramework contractor Manchester Road, Linthwaite, Huddersfield, UK, HD7 5QH
  • Tillomed Laboratories ltdFramework contractor 220 Butterfield, Great Marling, Luton, UK, LU2 8DL
  • medac Pharma LLPFramework contractor Scion House, Stirling University Innovation Park, Sterling, UK, FK9 4NF

Official documents & specifications

Official links; attachments are not copied

No document links were published on the notice.